Flock, smart-money disclosures made readable

Monopar Therapeutics Inc

MNPRNASDAQ · US

Sign in for alerts Sign in to add to portfolio

Holders

Ownership

Ownership data not yet available for this security.

Disclosure timeline

REDUCEDT+7
Starr Christopher M
Monopar Therapeutics Inc · NASDAQ
−2,970 sh · $234.1K
Filed 5 Oct 2026SEC Form 4view source
ACQUIREDT+7
Starr Christopher M
Monopar Therapeutics Inc · NASDAQ
+8,400 sh · $42
Filed 5 Oct 2026SEC Form 4view source
REDUCEDT+7
Starr Christopher M
Monopar Therapeutics Inc · NASDAQ
−799 sh · $63.7K
Filed 5 Oct 2026SEC Form 4view source
REDUCEDT+7
Starr Christopher M
Monopar Therapeutics Inc · NASDAQ
−4,631 sh · $361.6K
Filed 5 Oct 2026SEC Form 4view source
ACQUIREDT+30
Cittadine Andrew
Monopar Therapeutics Inc · NASDAQ
+4,384 sh
Filed 2 Oct 2026SEC Form 4view source
REDUCEDT+30
Cittadine Andrew
Monopar Therapeutics Inc · NASDAQ
−1,944 sh · $154.9K
Filed 2 Oct 2026SEC Form 4view source
ACQUIREDT+30
Robinson Chandler
Monopar Therapeutics Inc · NASDAQ
+15,000 sh · $210.0K
Filed 28 Sept 2026SEC Form 4view source
ACQUIREDT+30
Robinson Chandler
Monopar Therapeutics Inc · NASDAQ
+14,056 sh · $421.7K
Filed 28 Sept 2026SEC Form 4view source
REDUCEDT+30
Robinson Chandler
Monopar Therapeutics Inc · NASDAQ
−8,368 sh · $744.5K
Filed 28 Sept 2026SEC Form 4view source
REDUCEDT+30
Robinson Chandler
Monopar Therapeutics Inc · NASDAQ
−600 sh · $53.9K
Filed 28 Sept 2026SEC Form 4view source

Announcements

No announcements on record for this security.

Show all 28 disclosures

REDUCEDT+30
Robinson Chandler
Monopar Therapeutics Inc · NASDAQ
−9,638 sh · $847.8K
Filed 28 Sept 2026SEC Form 4view source
REDUCEDT+30
Robinson Chandler
Monopar Therapeutics Inc · NASDAQ
−10,450 sh · $910.7K
Filed 28 Sept 2026SEC Form 4view source
REDUCEDStale
Tsuchimoto Kim R
Monopar Therapeutics Inc · NASDAQ
−485 sh · $52.8K
Filed 28 Aug 2026SEC Form 4view source
ACQUIREDStale
Anderson Raymond
Monopar Therapeutics Inc · NASDAQ
+1,740 sh · $52.2K
Filed 28 Aug 2026SEC Form 4view source
REDUCEDStale
Tsuchimoto Kim R
Monopar Therapeutics Inc · NASDAQ
−615 sh · $67.4K
Filed 28 Aug 2026SEC Form 4view source
REDUCEDStale
Tsuchimoto Kim R
Monopar Therapeutics Inc · NASDAQ
−700 sh · $77.5K
Filed 28 Aug 2026SEC Form 4view source
ACQUIREDStale
Tsuchimoto Kim R
Monopar Therapeutics Inc · NASDAQ
+2,055 sh · $61.6K
Filed 28 Aug 2026SEC Form 4view source
ACQUIREDStale
Anderson Raymond
Monopar Therapeutics Inc · NASDAQ
+1,402 sh · $42.1K
Filed 28 Aug 2026SEC Form 4view source
REDUCEDStale
Tsuchimoto Kim R
Monopar Therapeutics Inc · NASDAQ
−1,098 sh · $122.8K
Filed 28 Aug 2026SEC Form 4view source
REDUCEDStale
Anderson Raymond
Monopar Therapeutics Inc · NASDAQ
−694 sh · $76.4K
Filed 28 Aug 2026SEC Form 4view source
REDUCEDStale
Tsuchimoto Kim R
Monopar Therapeutics Inc · NASDAQ
−602 sh · $68.0K
Filed 28 Aug 2026SEC Form 4view source
REDUCEDStale
Tsuchimoto Kim R
Monopar Therapeutics Inc · NASDAQ
−590 sh · $67.2K
Filed 28 Aug 2026SEC Form 4view source
REDUCEDStale
Anderson Raymond
Monopar Therapeutics Inc · NASDAQ
−646 sh · $71.8K
Filed 28 Aug 2026SEC Form 4view source
REDUCEDStale
Anderson Raymond
Monopar Therapeutics Inc · NASDAQ
−1,802 sh · $203.7K
Filed 28 Aug 2026SEC Form 4view source
ACQUIREDStale
Tsuchimoto Kim R
Monopar Therapeutics Inc · NASDAQ
+2,035 sh · $28.5K
Filed 28 Aug 2026SEC Form 4view source
ACQUIREDStale
Rioux Patrice
Monopar Therapeutics Inc · NASDAQ
+1,380 sh · $7
Filed 27 Aug 2026SEC Form 4view source
REDUCEDStale
Rioux Patrice
Monopar Therapeutics Inc · NASDAQ
−1 sh · $111
Filed 27 Aug 2026SEC Form 4view source
DISCLOSEDStale
Two Sigma Investments
Monopar Therapeutics Inc · NASDAQ
9,765 sh · $535.0K
Filed 31 Mar 2026SEC 13Fview source